The Molecular Examiner

Glossary

Key terms.

53 entries across 5 categories. Each entry links to a related article where one exists. Alphabetical within each category.

Compounds

Amylin
A 37-amino-acid peptide co-secreted with insulin from pancreatic beta cells. Modulates gastric emptying, glucagon suppression, and central satiety.
Related note →
BPC-157
Body Protection Compound. A 15-amino-acid synthetic peptide derived from a sequence in gastric juice. One of the most-studied tissue-research peptides.
Related note →
Cagrilintide
A long-acting amylin analog engineered for once-weekly administration. Studied in combination with incretin agonists in metabolic research.
Related note →
CJC-1295
A long-acting GHRH analog with an albumin-binding modification. Developed at ConjuChem in Montreal (Teichman et al. 2006).
GHK-Cu
Glycyl-L-histidyl-L-lysine bound to copper(II). A tripeptide-metal complex studied in tissue-research and cosmetic literature.
Related note →
GIP
Glucose-dependent Insulinotropic Polypeptide. An incretin hormone released from the gut that triggers insulin secretion. The "G" in dual-agonists like tirzepatide.
Related note →
GLP-1
Glucagon-Like Peptide-1. The most-studied incretin hormone. Native ligand for GLP-1R.
Related note →
Hexarelin
A hexapeptide GHRP developed in Italy in the early 1990s. Less selective than ipamorelin — raises cortisol and prolactin alongside GH.
Insulin
The original peptide drug. Isolated in Toronto 1921 (Banting & Best); sequenced in Cambridge 1958 (Sanger); first total synthesis Shanghai 1965.
Ipamorelin
A selective pentapeptide ghrelin-receptor agonist. Triggers pulsatile GH release without affecting cortisol or prolactin.
Related note →
Oxytocin
The first peptide hormone ever chemically synthesized in the laboratory. Vincent du Vigneaud, Cornell 1953. Nobel Prize 1955.
Retatrutide
A GLP-1 / GIP / glucagon triple agonist in clinical research. The next-generation analog of tirzepatide.
Semaglutide
A long-acting GLP-1 receptor agonist. The single-receptor counterpart to tirzepatide.
Related note →
Somatostatin
A 14-residue cyclic peptide that inhibits both growth-hormone and insulin secretion. Discovered by Guillemin at the Salk Institute, 1973.
TB-500
A 17-amino-acid fragment of Thymosin Beta-4. Studied in tissue-repair research, frequently paired with BPC-157.
Related note →
Tirzepatide
The first approved dual GLP-1 / GIP receptor agonist. A 39-amino-acid peptide engineered for once-weekly administration.
Related note →

Receptors

AMY1-R
Calcitonin-receptor / RAMP1 heterodimer. The principal amylin receptor.
GHSR-1a
Growth-Hormone Secretagogue Receptor 1a. The ghrelin receptor. The binding site for ipamorelin and other GHRPs.
GIPR
The GIP receptor. A class-B GPCR on pancreatic beta cells. One of two receptors tirzepatide engages.
GLP-1R
The GLP-1 receptor. The most-studied incretin GPCR. Target of semaglutide, liraglutide, and the GLP-1 side of tirzepatide.
GPCR
G-Protein-Coupled Receptor. The seven-transmembrane receptor superfamily. Most peptide-hormone receptors are class-B GPCRs.

Techniques

Bacteriostatic water
Sterile water containing 0.9% benzyl alcohol as preservative. The standard reconstitution solvent for research peptides; provides a ~28-day refrigerated storage window.
Related note →
ESI-MS
Electrospray-Ionization Mass Spectrometry. A standard mass-spec method for peptide identity confirmation. Reads multiply-charged ions in the m/z 500–2000 range.
Fmoc
9-fluorenylmethoxycarbonyl. A protecting group used in solid-phase peptide synthesis. The modern default chemistry.
Related note →
HPLC
High-Performance Liquid Chromatography. The standard analytical method for research peptide purity. Reverse-phase with C18 column and UV detection at 220 nm is the default.
Related note →
LAL assay
Limulus Amebocyte Lysate. Classical endotoxin assay using horseshoe-crab blood. Reports EU/mg.
Lyophilization
Freeze-drying. The default preservation method for research peptides. Produces a stable solid that can be reconstituted with appropriate solvent.
Related note →
MALDI-TOF
Matrix-Assisted Laser Desorption / Ionization Time-Of-Flight. A mass-spec method common in peptide labs. Reads predominantly singly-charged ions.
Mass spectrometry
Analytical technique that measures molecular mass. Used in peptide COAs to confirm identity. Standard methods: MALDI-TOF, ESI-MS.
Related note →
rFC assay
Recombinant Factor C assay. The modern endotoxin alternative to LAL — recombinant, no horseshoe-crab dependency.
SPPS
Solid-Phase Peptide Synthesis. The Merrifield (1963) chemistry that anchors peptide synthesis to a resin bead, enabling routine peptide manufacturing.
Related note →

Concepts

AUC
Area Under the Curve. The integrated drug exposure over time. The primary pharmacokinetic readout for peptide therapeutics.
Counter-ion
The non-peptide ion accompanying the peptide in solid form. Typically TFA (trifluoroacetate) or acetate. Affects solubility and assay compatibility.
Related note →
Endotoxin
Lipopolysaccharide from Gram-negative bacterial cell walls. Activates TLR4; can confound inflammation assays. Measured in EU/mg via LAL or rFC assay.
Related note →
Half-life
The time for serum drug concentration to drop by half. For peptide therapeutics, ranges from minutes (ipamorelin ~2 h) to days (semaglutide ~168 h).
Hydrolysis
Cleavage of a peptide bond by water. The dominant degradation pathway for peptides in aqueous solution. Slowed by lyophilization and refrigeration.
Incretin
A class of gut-derived hormones that potentiate insulin release in response to a meal. GLP-1 and GIP are the canonical examples.
Net peptide mass
The mass of pure peptide in a vial, distinct from gross vial mass. Gross = peptide + counter-ion + water. Critical for concentration-sensitive research.
Related note →
Peptide bond
The covalent amide bond linking adjacent amino acids in a peptide chain. The C–N bond formed by condensing a carboxyl and an amine.
Peptide content
The percentage of the gross vial mass that is actual peptide. Typically 70-90% — the rest is counter-ions and water.
Related note →
Pulsatile GH release
The endogenous pattern of growth-hormone secretion: large pulses followed by trough periods. Functionally distinct from continuous exogenous GH.
Related note →
Purity (HPLC area %)
Peptide purity measured as the integrated area of the target peak divided by total integrated peak area in an HPLC chromatogram.
Related note →
Receptor selectivity
The relative affinity of a ligand for its intended receptor versus other receptors. Ipamorelin is the canonical example of a clean GHRP selectivity profile.

Regulatory & documentation

Bioburden
Total microbial contamination in a sample. Reported in colony-forming units per gram (CFU/g). Reference threshold: <100 CFU/g.
Related note →
CDMO
Contract Development and Manufacturing Organization. The companies that synthesize peptide API at scale for the global research market.
Certificate of Analysis (COA)
The supplier's per-lot documentation of identity, purity, and content. Should include HPLC chromatogram, mass spec, counter-ion identity, and peptide content.
Related note →
EMA
European Medicines Agency. The European regulatory authority for medicinal products.
FDA
United States Food and Drug Administration. The US regulatory authority for pharmaceuticals.
GMP
Good Manufacturing Practice. The quality-assurance regulatory framework that governs pharmaceutical manufacturing.
Lot number
The unique identifier for a specific manufacturing batch. Should appear on both the vial and the matching Certificate of Analysis.
Lyophilized
Freeze-dried. The default storage form for research peptides. Stable at -20°C for years if kept dry.
Related note →
Research Use Only
A regulatory designation indicating the compound is intended for laboratory and educational research, not human consumption.
TFA
Trifluoroacetate. The standard counter-ion produced by preparative HPLC peptide purification.
Related note →